ArticleJournal of experimental orthopaedics2026
Quadriceps tendon autograft for ACL reconstruction: A global survey from the International Quadriceps Tendon Interest Group.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anterior Cruciate Ligament Reconstruction: Clinical Outcomes and Biomechanical Considerations of Graft Selection-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate current preferences, techniques and indications regarding the use of the quadriceps tendon (QT) autograft for anterior cruciate ligament reconstruction (ACLR) among members of the International Quadriceps Tendon Interest (IQTI) group. Methods: An online survey consisting of 30 single- and multiple-choice questions was distributed to all IQTI members ( Results: Thirty-two high-volume, experienced surgeons completed the questionnaire (32/45; response rate, 71%; 28 male and 4 female). The QT was the preferred primary graft choice for ACLR in 61% ( Conclusion: This international survey shows that the QT autograft is a well-established option in ACLR among experienced knee surgeons, particularly in revision and complex settings. At the same time, persistent variability in primary graft selection and reported rehabilitation and technical considerations indicate that QT use remains individualized within a spectrum of effective autograft choices. Level of Evidence: Level V, expert statement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.